A new blood test may more accurately identify blood signatures, or biomarkers, for Parkinson’s disease (PD), according to a new study published in the journal Movement Disorders. The study, conducted by researchers at Mount Sinai and funded by the Michael J. Fox Foundation for Parkinson’s Research, applies a new approach to looking for blood biomarkers for both patients with and without a known genetic risk factor for PD.
While biomarkers — such as bad cholesterol level in the case of heart disease — hasten diagnoses by offering accurate measures of disease progression, there are currently no fully validated biomarkers for PD
READ FULL ARTICLE From Medical Express